tiprankstipranks
Trending News
More News >
Evofem Biosciences (EVFM)
OTHER OTC:EVFM
US Market
Advertisement

Evofem Biosciences (EVFM) Ratios

Compare
1,214 Followers

Evofem Biosciences Ratios

EVFM's free cash flow for Q2 2025 was $―. For the 2025 fiscal year, EVFM's free cash flow was decreased by $ and operating cash flow was $―. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
0.08 0.13 0.14 0.14 1.26
Quick Ratio
0.05 0.10 0.08 0.08 1.17
Cash Ratio
<0.01 <0.01 0.03 0.06 0.63
Solvency Ratio
-0.03 0.71 -0.77 -13.99 -1.30
Operating Cash Flow Ratio
-0.05 -0.12 -0.75 -1.07 -1.36
Short-Term Operating Cash Flow Coverage
-0.08 -0.21 -1.04 -1.32 -1.92
Net Current Asset Value
$ -76.59M$ -67.85M$ -84.26M$ 4.74M$ -10.89M
Leverage Ratios
Debt-to-Assets Ratio
3.55 4.11 2.83 6.01 0.78
Debt-to-Equity Ratio
-0.66 -0.65 -0.99 24.41 63.80
Debt-to-Capital Ratio
-1.92 -1.87 -105.85 0.96 0.98
Long-Term Debt-to-Capital Ratio
0.00 0.00 -0.05 0.48 0.96
Financial Leverage Ratio
-0.19 -0.16 -0.35 4.06 81.64
Debt Service Coverage Ratio
-0.02 -0.37 -1.22 -1.49 -1.89
Interest Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
38.49 140.07 18.92 2.34 0.48
Interest Debt Per Share
<0.01 8.99 151.34 1.65K 2.15K
Net Debt to EBITDA
-60.59 -2.66 -0.82 -0.65 -0.36
Profitability Margins
Gross Profit Margin
78.83%64.26%73.78%50.81%-4.93%
EBIT Margin
-22.43%-97.96%-499.64%-2023.30%-23234.08%
EBITDA Margin
-4.52%-88.19%-493.61%-2010.89%-23166.37%
Operating Profit Margin
-27.13%-97.96%-499.64%-2023.30%-23234.08%
Pretax Profit Margin
-18.64%290.90%-455.27%-2488.78%-31906.95%
Net Profit Margin
-18.64%290.81%-455.53%-2488.99%-31907.85%
Continuous Operations Profit Margin
-18.64%290.81%-455.53%-2488.99%-31907.85%
Net Income Per EBT
100.00%99.97%100.06%100.01%100.00%
EBT Per EBIT
68.70%-296.95%91.12%123.01%137.33%
Return on Assets (ROA)
-24.04%501.98%-304.80%-1066.65%-129.41%
Return on Equity (ROE)
4.56%-79.66%106.82%-4328.95%-10564.88%
Return on Capital Employed (ROCE)
7.77%28.83%122.51%140.85%-317.04%
Return on Invested Capital (ROIC)
36.76%96.21%-5135.59%-2246.06%-115.56%
Return on Tangible Assets
-48.44%501.98%-304.80%-1066.65%-129.41%
Earnings Yield
-5.08%17150.15%-2039.84%-415.79%-78.73%
Efficiency Ratios
Receivables Turnover
14.45 3.17 14.95 1.28 0.34
Payables Turnover
0.31 0.38 0.29 0.39 0.04
Inventory Turnover
1.55 3.84 0.82 0.53 0.07
Fixed Asset Turnover
34.52 13.92 2.02 0.74 0.04
Asset Turnover
1.29 1.73 0.67 0.43 <0.01
Working Capital Turnover Ratio
-0.25 -0.25 -0.17 -0.17 0.03
Cash Conversion Cycle
-905.26 -743.90 -769.66 47.71 -1.64K
Days of Sales Outstanding
25.26 114.96 24.41 285.53 1.08K
Days of Inventory Outstanding
234.99 95.12 444.70 690.75 5.59K
Days of Payables Outstanding
1.17K 953.98 1.24K 928.57 8.30K
Operating Cycle
260.25 210.08 469.11 976.28 6.66K
Cash Flow Ratios
Operating Cash Flow Per Share
>-0.01 -1.86 -149.81 -2.10K -2.62K
Free Cash Flow Per Share
>-0.01 -1.86 -150.53 -2.14K -2.68K
CapEx Per Share
0.00 <0.01 0.73 41.99 56.35
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.02 1.02
Dividend Paid and CapEx Coverage Ratio
-1.15K -2.24K -206.48 -49.90 -46.51
Capital Expenditure Coverage Ratio
0.00 -2.24K -206.48 -49.90 -46.51
Operating Cash Flow Coverage Ratio
-0.08 -0.21 -0.99 -1.27 -1.22
Operating Cash Flow to Sales Ratio
-0.21 -0.49 -4.18 -17.79 -235.04
Free Cash Flow Yield
-290.59%-2904.38%-1881.68%-303.15%-59.24%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-19.67 <0.01 -0.05 -0.24 -1.27
Price-to-Sales (P/S) Ratio
0.07 0.02 0.22 5.99 405.27
Price-to-Book (P/B) Ratio
-0.88 >-0.01 -0.05 10.41 134.19
Price-to-Free Cash Flow (P/FCF) Ratio
-0.34 -0.03 -0.05 -0.33 -1.69
Price-to-Operating Cash Flow Ratio
-17.66 -0.03 -0.05 -0.34 -1.72
Price-to-Earnings Growth (PEG) Ratio
-0.23 >-0.01 <0.01 0.01 0.11
Price-to-Fair Value
-0.88 >-0.01 -0.05 10.41 134.19
Enterprise Value Multiple
-62.17 -2.68 -0.87 -0.95 -2.11
Enterprise Value
46.69M 43.10M 72.12M 157.30M 217.80M
EV to EBITDA
-62.17 -2.68 -0.87 -0.95 -2.11
EV to Sales
2.81 2.37 4.28 19.08 488.34
EV to Free Cash Flow
-13.54 -4.80 -1.02 -1.05 -2.03
EV to Operating Cash Flow
-13.54 -4.81 -1.02 -1.07 -2.08
Tangible Book Value Per Share
-0.01 -13.78 -152.77 67.71 33.67
Shareholders’ Equity Per Share
-0.01 -13.78 -152.77 67.71 33.67
Tax and Other Ratios
Effective Tax Rate
0.00 <0.01 >-0.01 >-0.01 >-0.01
Revenue Per Share
<0.01 3.77 35.82 117.77 11.15
Net Income Per Share
>-0.01 10.98 -163.19 -2.93K -3.56K
Tax Burden
1.00 1.00 1.00 1.00 1.00
Interest Burden
0.83 -2.97 0.91 1.23 1.37
Research & Development to Revenue
0.38 0.16 1.49 4.02 38.23
SG&A to Revenue
0.67 0.82 1.64 3.00 67.46
Stock-Based Compensation to Revenue
0.04 0.07 0.20 1.08 28.47
Income Quality
1.11 -0.17 0.92 0.71 0.74
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis